{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T14:17:09Z","timestamp":1784557029718,"version":"3.55.0"},"reference-count":22,"publisher":"Bioscientifica","content-domain":{"domain":["edm.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2014,5,1]]},"abstract":"Summary<\/jats:title>\n This paper reports on two patients with a long-standing diagnosis of an ENETS stage IV neuroendocrine tumour (NET) of the small intestine who developed neurological symptoms. The first patient only had bulbar symptoms and tested positive for acetylcholine receptor antibodies. The second patient had more classical symptoms of fatigable diplopia and muscle weakness of the legs, but no detectable antibodies. The diagnosis of paraneoplastical myasthenia gravis (MG) was postulated. Both patients were treated with pyridostigmine for MG and octreotide for the NETs. Interestingly, treatment of the NETs resulted in improvement of myasthenic symptoms. Paraneoplastic MG has been described to occur with certain malignancies, mainly thymoma. Herein, we prove that the association with gastrointestinal NETs, however, rare, is also one to be considered by clinicians dealing with either of these diseases. The pathogenesis has yet to be elucidated.<\/jats:p>\n \n Learning points<\/jats:title>\n \n \n \n NETs are rare malignancies with a wide variety of symptoms.<\/jats:p>\n <\/jats:list-item>\n \n Paraneoplastic MG can occur with various types of malignancies.<\/jats:p>\n <\/jats:list-item>\n \n Herein, we provide evidence of paraneoplastic MG in association with a grade IV NET of the small intestine.<\/jats:p>\n <\/jats:list-item>\n \n Treatment of the NETs resulted in remission of myasthenic symptoms in one patient.<\/jats:p>\n <\/jats:list-item>\n <\/jats:list>\n <\/jats:p>\n <\/jats:sec>","DOI":"10.1530\/edm-14-0013","type":"journal-article","created":{"date-parts":[[2014,5,15]],"date-time":"2014-05-15T05:37:51Z","timestamp":1400132271000},"update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-2","source":"Crossref","is-referenced-by-count":4,"title":["Two patients with a neuroendocrine tumour of the small intestine and paraneoplastic myasthenia gravis"],"prefix":"10.1530","volume":"2014","author":[{"given":"M A W","family":"Hermans","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B M L","family":"Stelten","sequence":"additional","affiliation":[{"name":"1Department of Neurology, Canisius Wilhelmina Hospital, Weg door Jonkerbos 100, 6532SZ, Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H R","family":"Haak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W W","family":"de Herder","sequence":"additional","affiliation":[{"name":"2Department of Internal Medicine, Erasmus University Medical Centre, Gravendijkwal 230, 3015CE, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M W","family":"Dercksen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","reference":[{"key":"ref61","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1590\/S0004-27302005000500028","article-title":"Carcinoid syndrome: diagnosis and medical management","volume":"49","year":"2005","journal-title":"Arquivos Brasileiros de Endocrinologia e Metabologia"},{"key":"ref201","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1136\/jnnp.2008.169367","article-title":"Myasthenia and related disorders of the neuromuscular junction","volume":"81","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"key":"ref151","first-page":"3","article-title":"Epidemiology of neuroendocrine tumours","volume":"80","year":"2008","journal-title":"Neuroendocrinology"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1136\/jnnp.48.7.719","article-title":"Myasthenia gravis associated with a hormone producing malignant carcinoid tumour","volume":"48","year":"1985","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"key":"ref181","doi-asserted-by":"crossref","first-page":"4656","DOI":"10.1200\/JCO.2009.22.8510","article-title":"Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group","volume":"27","year":"2009","journal-title":"Journal of Clinical Oncology"},{"key":"ref111","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1212\/WNL.52.7.1490","article-title":"Neuroendocrine lung tumors and disorders of the neuromuscular junction","volume":"52","year":"1999","journal-title":"Neurology"},{"key":"ref11","first-page":"309149","article-title":"Unusual paraneoplastic syndrome accompanies neuroendocrine tumours of the pancreas","volume":"2011","year":"2011","journal-title":"Case Reports in Medicine"},{"key":"ref191","doi-asserted-by":"publisher","first-page":"32010","DOI":"10.1016\/S0305-7372(10)70026-8","article-title":"Biological targeted therapies in patients with advanced enteropancreatic neuroendocrine carcinomas Treatment","author":"FaveG","year":"2010","journal-title":"Cancer Reviews"},{"key":"ref101","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1111\/j.1468-1331.2008.02242.x","article-title":"Paraneoplastic myasthenia gravis: immunological and clinical aspects","volume":"15","year":"2008","journal-title":"European Journal of Neurology"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"4656","DOI":"10.1200\/JCO.2009.22.8510","article-title":"Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group","volume":"27","year":"2009","journal-title":"Journal of Clinical Oncology"},{"key":"ref41","first-page":"3","article-title":"Epidemiology of neuroendocrine tumours","volume":"80","year":"2008","journal-title":"Neuroendocrinology"},{"key":"ref81","doi-asserted-by":"publisher","first-page":"32010","DOI":"10.1016\/S0305-7372(10)70026-8","article-title":"Biological targeted therapies in patients with advanced enteropancreatic neuroendocrine carcinomas Treatment","author":"FaveG","year":"2010","journal-title":"Cancer Reviews"},{"key":"ref91","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1136\/jnnp.2008.169367","article-title":"Myasthenia and related disorders of the neuromuscular junction","volume":"81","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"key":"ref171","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1590\/S0004-27302005000500028","article-title":"Carcinoid syndrome: diagnosis and medical management","volume":"49","year":"2005","journal-title":"Arquivos Brasileiros de Endocrinologia e Metabologia"},{"key":"ref211","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1111\/j.1468-1331.2008.02242.x","article-title":"Paraneoplastic myasthenia gravis: immunological and clinical aspects","volume":"15","year":"2008","journal-title":"European Journal of Neurology"},{"key":"ref01","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1212\/WNL.52.7.1490","article-title":"Neuroendocrine lung tumors and disorders of the neuromuscular junction","volume":"52","year":"1999","journal-title":"Neurology"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"371","DOI":"10.3109\/10428194.2011.615426","article-title":"Myasthenia gravis, an autoimmune manifestation of lymphoma and lymphoproliferative disorders: case reports and review of literature","volume":"53","year":"2012","journal-title":"Leukemia & Lymphoma"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S1470-2045(07)70410-2","article-title":"Gastroenteropancreatic neuroendocrine tumours","volume":"9","journal-title":"Lancet Oncology"},{"key":"ref121","first-page":"309149","article-title":"Unusual paraneoplastic syndrome accompanies neuroendocrine tumours of the pancreas","volume":"2011","year":"2011","journal-title":"Case Reports in Medicine"},{"key":"ref131","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1136\/jnnp.48.7.719","article-title":"Myasthenia gravis associated with a hormone producing malignant carcinoid tumour","volume":"48","year":"1985","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"key":"ref161","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S1470-2045(07)70410-2","article-title":"Gastroenteropancreatic neuroendocrine tumours","volume":"9","journal-title":"Lancet Oncology"},{"key":"ref141","doi-asserted-by":"crossref","first-page":"371","DOI":"10.3109\/10428194.2011.615426","article-title":"Myasthenia gravis, an autoimmune manifestation of lymphoma and lymphoproliferative disorders: case reports and review of literature","volume":"53","year":"2012","journal-title":"Leukemia & Lymphoma"}],"container-title":["Endocrinology, Diabetes & Metabolism Case Reports"],"original-title":[],"link":[{"URL":"https:\/\/edm.bioscientifica.com\/view\/journals\/edm\/2014\/1\/EDM14-0013.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/edm.bioscientifica.com\/downloadpdf\/journals\/edm\/2014\/1\/EDM14-0013.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T13:45:54Z","timestamp":1784555154000},"score":1,"resource":{"primary":{"URL":"http:\/\/journals.bioscientifica.com\/edm\/article\/2985"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,1]]},"references-count":22,"URL":"https:\/\/doi.org\/10.1530\/edm-14-0013","relation":{},"ISSN":["2052-0573"],"issn-type":[{"value":"2052-0573","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,1]]}}}